Prevalence of hypogonadism in males aged at least 45 years: the HIM study - Mulligan, T.; Frick, M. F.; Zuraw, Q. C.; Stemhagen, A.; McWhirter, C. (Int J Clin Pract, 2006)

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline - Bhasin, S.; Cunningham, G. R.; Hayes, F. J.; Matsumoto, A. M.; Snyder, P. J.; Swerdloff, R. S.; Montori, V. M. (J Clin Endocrinol Metab, 2010)

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging - Harman, S. M.; Metter, E. J.; Tobin, J. D.; Pearson, J.; Blackman, M. R. (J Clin Endocrinol Metab, 2001)

The emerging link between hypogonadism and metabolic syndrome - Guay, A. T. (J Andol, 2009)

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report (Circulation, 2002)

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement - Grundy, S. M.; Cleeman, J. I.; Daniels, S. R.; Donato, K. A.; Eckel, R. H.; Franklin, B. A.; Gordon, D. J.; Krauss, R. M.; Savage, P. J.; Smith, S. C.; Spertus, J. A.; Costa, F. (Circulation, 2005)

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management - Grundy, S. M.; Hansen, B.; Smith, S. C.; Cleeman, J. I.; Kahn, R. A. (Circulation, 2004)

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men - Laaksonen, D. E.; Niskanen, L.; Punnonen, K.; Nyyssonen, K.; Tuomainen, T. P.; Valkonen, V. P.; Salonen, R.; Salonen, J. T. (Diabetes Care, 2004)

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis - Ding, E. L.; Song, Y.; Malik, V. S.; Liu, S. (JAMA, 2006)

Testosterone deficiency, insulin resistance and the metabolic syndrome - Zitzmann, M. (Nat Rev Endocrinol, 2009)

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men - Wang, C.; Swerdloff, R. S.; Iranmanesh, A.; Dobs, A.; Snyder, P. J.; Cunningham, G.; Matsumoto, A. M.; Weber, T.; Berman, N. (J Clin Endocrinol Metab, 2000)

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes - Kapoor, D.; Goodwin, E.; Channer, K. S.; Jones, T. H. (Eur J Endocrinol, 2006)

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes - Kapoor, D.; Clarke, S.; Stanworth, R.; Channer, K. S.; Jones, T. H. (Eur J Endocrinol, 2007)

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone - Heufelder, A. E.; Saad, F.; Bunck, M. C.; Gooren, L. (J Andol, 2009)

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome - Aversa, A.; Bruzziches, R.; Francomano, D.; Spera, G. (J Endocrinol Invest, 2010)

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study - Aversa, A.; Bruzziches, R.; Francomano, D.; Rosano, G.; Isidori, A. M.; Lenzi, A.; Spera, G. (J Sex Med, 2010)

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study) - Jones, T. H.; Arver, S.; Behre, H. M.; Buvat, J.; Meuleman, E.; Moncada, I.; Morales, A. M.; Volterrani, M.; Yellowlees, A.; Howell, J. D.; Channer, K. S. (Diabetes Care, 2011)

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blind placebo-controlled Moscow study - Kalinchenko, S. Y.; Tishova, Y. A.; Mskhalaya, G. J.; Gooren, L. J.; Giltay, E. J.; Saad, F. (Clin Endocrinol (Oxf), 2010)

Testosterone and metabolic syndrome: a meta-analysis study - Corona, G.; Monami, M.; Rastrelli, G.; Aversa, A.; Tishova, Y.; Saad, F.; Lenzi, A.; Forti, G.; Mannucci, E.; Maggi, M. (J Sex Med, 2011)

Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency - Miner, M. M.; Khera, M.; Bhattacharya, R.; Blick, G.; Kushner, H. (Postgrad Med, 2011)

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction - Traish, A. M.; Guay, A.; Feeley, R.; Saad, F. (J Andol, 2009)

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity - Alberti, K. G.; Eckel, R. H.; Grundy, S. M.; Zimmet, P. Z.; Cleeman, J. I.; Donato, K. A.; Fruchart, J. C.; James, W. P.; Loria, C. M.; Smith, S. C. (Circulation, 2009)

Endogenous sex hormones and metabolic syndrome in aging men - Muller, M.; Grobbee, D. E.; den Tonkelaar, I.; Lamberts, S. W.; van der Schouw, Y. T. (J Clin Endocrinol Metab, 2005)

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men - Kupelian, V.; Page, S. T.; Araujo, A. B.; Travison, T. G.; Bremner, W. J.; McKinlay, J. B. (J Clin Endocrinol Metab, 2006)

The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance - Traish, A. M.; Saad, F.; Guay, A. (J Andol, 2009)

Hypogonadotropic hypogonadism in men with type 2 diabetes - Dandona, P.; Dhindsa, S.; Chandel, A.; Chaudhuri, A. (Postgrad Med, 2009)

The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2 - Saad, F.; Gooren, L. J. (J Obes, 2011)

Waist circumference and testosterone levels in community dwelling men. The Tromso study - Svartberg, J.; von Muhlen, D.; Sundsfjord, J.; Jorde, R. (Eur J Epidemiol, 2004)

A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern - Rosmond, R.; Wallerius, S.; Wanger, P.; Martin, L.; Holm, G.; Bjorntorp, P. (J Intern Med, 2003)

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study - Stellato, R. K.; Feldman, H. A.; Hamdy, O.; Horton, E. S.; McKinlay, J. B. (Diabetes Care, 2000)

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III) - Selvin, E.; Feinleib, M.; Zhang, L.; Rohrmann, S.; Rifai, N.; Nelson, W. G.; Dobs, A.; Basaria, S.; Golden, S. H.; Platz, E. A. (Diabetes Care, 2007)

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism - Yialamas, M. A.; Dwyer, A. A.; Hanley, E.; Lee, H.; Pitteloud, N.; Hayes, F. J. (J Clin Endocrinol Metab, 2007)

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth - Basaria, S. (J Andol, 2008)

Effects of testosterone on type 2 diabetes and components of the metabolic syndrome - Jones, T. H. (J Diabetes, 2010)

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip - Svartberg, J.; Agledahl, I.; Figenschau, Y.; Sildnes, T.; Waterloo, K.; Jorde, R. (Int J Impot Res, 2008)

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency - Boyanov, M. A.; Boneva, Z.; Christov, V. G. (Aging Male, 2003)

The effects of testosterone treatment on body composition and metabolism in middle-aged obese men - Marin, P.; Holmang, S.; Jonsson, L.; Sjostrom, L.; Kvist, H.; Holm, G.; Lindstedt, G.; Bjorntorp, P. (Int J Obes Relat Metab Disord, 1992)

Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein - Haider, A.; Gooren, L. J.; Padungtod, P.; Saad, F. (Horm Molec Biol Clin Invest, 2010)

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men - Pitteloud, N.; Hardin, M.; Dwyer, A. A.; Valassi, E.; Yialamas, M.; Elahi, D.; Hayes, F. J. (J Clin Endocrinol Metab, 2005)

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men - Pitteloud, N.; Mootha, V. K.; Dwyer, A. A.; Hardin, M.; Lee, H.; Eriksson, K. F.; Tripathy, D.; Yialamas, M.; Groop, L.; Elahi, D.; Hayes, F. J. (Diabetes Care, 2005)

Impact of acute biochemical castration on insulin sensitivity in healthy adult men - Rabiee, A.; Dwyer, A. A.; Caronia, L. M.; Hayes, F. J.; Yialamas, M. A.; Andersen, D. K.; Thomas, B.; Torriani, M.; Elahi, D. (Endocr Res, 2010)

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/11/18/prepub